4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-030076
President and CEO acquired 11,753 shares (other)
From the SEC's structured data for this filing
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-030076
President and CEO acquired 11,753 shares (other)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…